348
KNDP 당뇨병 임상 진료지침 Clinical Practic

48. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 2006;86:658-63.
49. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000;17:507-11.
50. Ekpebegh CO, Coetzee EJ, van der Merwe L, et al. A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med 2007;24:253-8.
51. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:524-9.
52. Palomba S, Falbo A, Orio F, Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta analysis of randomized controlled trials. Fertil Steril 2009;92:1646-58.
53. Khattab S, Mohsen IA, Foutouh IA, et al. Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endoc 2006;22:680-4.
54. Tang T, Lord JM, Normal RJ, et al. Insulin-sensitizing drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010;11:CD003053.
55. Glueck CJ, Wang P, Kobayashi S, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77: 520-5.
56. Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010;95:E448-EE455.
57. Glueck CJ, Salehi M, Sieve L, et al. Growth, motor, and social development in breast- and formula-fed infants of metformin treated women with polycystic ovary syndrome. J Pediatr 2006; 148:628-32.
58. Hale TW, Kristensen JH, Hackett LP, et al. Transfer of metformin into human milk. Diabetologia 2002; 45:1509-14.
59. Feig DS, Briggs GG, Kraemer JM, et al. Transfer of glibenclamide and glipizide into breast milk. Diabetes Care 2005;28:1851-5.
60. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
61. Anderson K, Barbeau M-C, Blagrave P, et al. Recommendations for nutrition best practice in the management of gestational diabetes mellitus. Can J Diet Pract Res 2006;67:206-8.
62. Knopp RH, Magee MS, Raisys V, et al. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 1991;40(suppl 2):165-71.
63. Bung P, Bung C, Artal R, et al. Therapeutic exercise for insulin-requiring gestational diabetes: effects on the fetusd results of a randomized prospective longitudinal study. J Perinat Med 1993;21:125-37.
64. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333: 1237-41.
65. Hawkins JS, Casey BM, Lo JY, et al. Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstet Gynecol 2009;113:1307-12.
66. Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational diabetes mellitus (GDM). Comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes 1985;34(suppl 2): 101-5.
67. Leikin E, Jenkins JH, Graves WL. Prophylactic insulin in gestational diabetes. Obstet Gynecol 1987;70: 587-92.
68. Yogev Y, Ben-Haroush A, Chen R, et al. Diurnal glycemic profile in obese and normal weight non-diabetic pregnant women. Am J Obstet Gynecol 2004;191:949-53.
69. McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007;47:186-90.
70. Ornoy A, Ratzon N, Greenbaum C, et al. Neurobe-haviour of school age children born to diabetic mothers. Arch Dis Child Fetal Neonatal Ed 1998; 79:F94-9.
71. Hadden D. When and how to start insulin treat- ment in gestational diabetes: a UK perspective. Diabet Med 2001;18:960-4.
72. Kjos S, Schaefer-Graf U, Sardesi S, et al. A ran- domized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001;24: 1904-10.